These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 10710060)

  • 21. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.
    Abildgaard N; Brixen K; Eriksen EF; Kristensen JE; Nielsen JL; Heickendorff L
    Haematologica; 2004 May; 89(5):567-77. PubMed ID: 15136220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib.
    Tollin SR; Perlmutter S; Aloia JF
    J Bone Miner Res; 2000 Jul; 15(7):1412-6. PubMed ID: 10893692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
    de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH
    Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
    Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative impact of Crohn's disease on bone mineral mass.
    Thodis E; Rossos P; Habal F; Oreopoulos D
    J Musculoskelet Neuronal Interact; 2003 Sep; 3(3):246-50. PubMed ID: 15758348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
    Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
    Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
    Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment.
    Mora S; Weber G; Marenzi K; Signorini E; Rovelli R; Proverbio MC; Chiumello G
    J Bone Miner Res; 1999 Nov; 14(11):1971-7. PubMed ID: 10571698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
    Scharla SH; Minne HW; Lempert UG; Leidig G; Hauber M; Raedsch R; Ziegler R
    Exp Clin Endocrinol; 1994; 102(1):44-9. PubMed ID: 8005208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study.
    Weiss LA; Barrett-Connor E; von Mühlen D; Clark P
    J Bone Miner Res; 2006 May; 21(5):758-64. PubMed ID: 16734391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
    Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
    J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vitamin D receptor gene polymorphism and the rate of bone loss of the femur neck and lumbar spine in hemodialized patients with chronic renal failure].
    Karkoszka H; Chudek J; Strzelczyk P; Wiecek A; Schmidt-Gayk H; Ritz E; Kokot F
    Pol Merkur Lekarski; 1998 Oct; 5(28):199-202. PubMed ID: 10101442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes?
    Kaya A; Ozgocmen S; Kamanli A; Ardicoglu O
    Med Princ Pract; 2009; 18(6):470-6. PubMed ID: 19797924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density.
    Schneider DL; Barrett-Connor EL
    Arch Intern Med; 1997 Jun; 157(11):1241-5. PubMed ID: 9183236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.